Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism

BMC Medicine

Bryan A Liang²  Tim K Mackey¹ 

[1] Institute of Health Law Studies, California Western School of Law, San Diego, USA;San Diego Center for Patient Safety, University of California San Diego School of Medicine, San Diego, USA

关键词: Substandard medicines;    Fraudulent medicines;    Falsified medicines;    Drug supply chain;    Global health policy;    Global health governance;    Counterfeit medicines;   

Others  :  1127615
DOI  :  10.1186/1741-7015-11-233

 received in 2013-07-31, accepted in 2013-10-03,  发布年份 2013

【 摘 要 】

Background

Perhaps no greater challenge exists for public health, patient safety, and shared global health security, than fake/falsified/fraudulent, poor quality unregulated drugs, also commonly known as “counterfeit medicines”, now endemic in the global drug supply chain. Counterfeit medicines are prevalent everywhere, from traditional healthcare settings to unregulated sectors, including the Internet. These dangerous medicines are expanding in both therapeutic and geographic scope, threatening patient lives, leading to antimicrobial resistance, and profiting criminal actors.

Discussion

Despite clear global public health threats, surveillance for counterfeit medicines remains extremely limited, with available data pointing to an increasing global criminal trade that has yet to be addressed appropriately. Efforts by a variety of public and private sector entities, national governments, and international organizations have made inroads in combating this illicit trade, but are stymied by ineffectual governance and divergent interests. Specifically, recent efforts by the World Health Organization, the primary international public health agency, have failed to adequately incorporate the broad array of stakeholders necessary to combat the problem. This has left the task of combating counterfeit medicines to other organizations such as UN Office of Drugs and Crime and Interpol in order to fill this policy gap.

Summary

To address the current failure of the international community to mobilize against the worldwide counterfeit medicines threat, we recommend the establishment of an enhanced global health governance trilateral mechanism between WHO, UNODC, and Interpol to leverage the respective strengths and resources of these organizations. This would allow these critical organizations, already engaged in the fight against counterfeit medicines, to focus on and coordinate their respective domains of transnational crime prevention, public health, and law enforcement field operations. Specifically, by forming a global partnership that focuses on combating the transnational criminal and patient safety elements of this pre-eminent global health problem, there can be progress against counterfeit drugs and their purveyors.

【 授权许可】

   
2013 Mackey and Liang; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J, Garrett L, Kickbusch I, Kohler JC, Midha K, Newton PN, Nishtar S, Orhii P, McKee M: How to achieve international action on falsified and substandard medicines. BMJ 2012, 345:e7381.
• [2]Mackey TK, Liang BA: The global counterfeit drug trade: patient safety and public health risks. J Pharm Sci 2011, 100:4571-4579.
• [3]Mackey TK: Global health diplomacy and the governance of counterfeit medicines: a mapping exercise of institutional approaches. J Health Diplomacy 2013., 1
• [4]Institute of Medicine: Countering the problem of falsified and substandard drugs. http://www.iom.edu/Reports/2013/Countering-the-Problem-of-Falsified-and-Substandard-Drugs.aspx webcite
• [5]United Nations Office on Drugs and Crime: Resolution 20/6: Countering fraudulent medicines, in particular their trafficking. http://www.unodc.org/documents/commissions/CCPCJ/CCPCJ-ECOSOC/CCPCJ-ECOSOC-00/CCPCJ-ECOSOC-11/Resolution_20-6.pdf webcite
• [6]Interpol: Pharmaceutical crime: A major threat to public health. http://www.interpol.int/Crime-areas/Pharmaceutical-crime/Pharmaceutical-crime webcite
• [7]World Health Organisation: Options for the structure and governance of the Member State mechanism on substandard/spurious/ falsely-labelled/falsified/counterfeit medical products: Report by the Secretariat. http://apps.who.int/gb/ssffc/pdf_files/A_MSM1_3-en.pdf webcite
• [8]International Federation of Pharmaceutical Manufacturers & Associations: The IFPMA Ten Principles on Counterfeit Medicines. http://www.ifpma.org/fileadmin/content/News/2010/IFPMA_Ten_Principles_on_Counterfeit_Medicines_12May2010.pdf webcite
• [9]World Customs Organization: Cotonou Declaration against fake medicines, 12 October 2009, Cotonou (Benin). http://www.wcoomd.org/en/topics/enforcement-and-compliance/activities-and-programmes/~/media/WCO/Public/Global/PDF/Topics/Enforcement%20and%20Compliance/Activities%20and%20Programmes/IPR/Cotonou%20Declaration/Announcement%20on%20Cotonou%20Declaration%20UK.ashx webcite
• [10]Kingdon JW, Thurber JA: Agendas, Alternatives, and Public Policies, Update Edition, with an Epilogue on Health Care. Addison-Wesley Longman; 2010.
• [11]World Health Organization: Medicines: counterfeit medicines. http://www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index.html webcite
• [12]World Health Organization: Growing threat from counterfeit medicines. Bull World Health Organ 2010, 247-248.
• [13]Fighting fake drugs: the role of WHO and pharma Lancet 2011, 377:1626.
• [14]Organisation for Economic Co-Operation and Development: The Economic Impact of Counterfeiting and Piracy. Paris, France: OECD Publishing; 2008:1-399. [Organisation for Economic Co-Operation and Development]
• [15]Customs group to fight $200 bln bogus drug industry. http://www.reuters.com/article/2010/06/10/us-customs-drugs-idUSTRE65961U20100610 webcite
• [16]Gostin LO, Buckley GJ, Kelley PW: Stemming the global trade in falsified and substandard MedicinesStemming the global trade in substandard medicines. JAMA 2013, 309:1693-1694.
• [17]Cohen JC, Mrazek M, Hawkins L: Tackling corruption in the pharmaceutical systems worldwide with courage and conviction. Clin Pharmacol Ther 2007, 81:445-449.
• [18]World Health Organization: Counterfeit medicines: an update on estimates 15 November 2006. http://www.who.int/medicines/services/counterfeit/impact/TheNewEstimatesCounterfeit.pdf webcite
• [19]Liang BA, Mackey T: Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales. Am J Law Med 2009, 35:125-184.
• [20]Mackey TK, Liang BA: Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health. Global Health 2013., 9
• [21]Campbell N, Clark JP, Stecher VJ, Goldstein I: Internet-ordered Viagra (sildenafil citrate) is rarely genuine. J Sex Med 2012, 9:2943-2951.
• [22]Liang BA, Mackey TK: Vaccine shortages and suspect online pharmacy sellers. Vaccine 2012, 30:105-108.
• [23]Forman RF: Availability of opioids on the internet. JAMA 2003, 290:889.
• [24]Forman RF, Block LG: The marketing of opioid medications without prescription over the internet. J Publ Pol Market 2006, 25:133-146.
• [25]Mackey TK, Liang BA: Oncology and the internet: regulatory failure and reform. J Oncol Pract 2012, 8:341-343.
• [26]Khan MH, Tanimoto T, Nakanishi Y, Yoshida N, Tsuboi H, Kimura K: Public health concerns for anti-obesity medicines imported for personal use through the internet: a cross-sectional study. BMJ Open 2012., 2
• [27]Interpol: Operations. http://www.interpol.int/Crime-areas/Pharmaceutical-crime/Operations/Operation-Pangea webcite
• [28]Pharmaceutical Security Institute: Incident Trends. http://www.psi-inc.org/incidentTrends.cfm webcite
• [29]Pharmaceutical Security Institute: Counterfeit Situation: Therapeutic Categories. http://www.psi-inc.org/therapeuticCategories.cfm webcite
• [30]Pharmaceutical Security Institute: Counterfeit Situation - Definitions. http://www.psi-inc.org/counterfeitSituation.cfm webcite
• [31]World Health Organization: WHO’s relationship with the International Medical Products Anti-Counterfeiting Taskforce. http://apps.who.int/gb/ssffc/pdf_files/A_SSFFC_WG4-en.pdf webcite
• [32]World Health Organization: Substandard/Spurious/Falsely-Labelled/ Falsified/Counterfeit Medical Products: Report by the Director-General. http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_16-en.pdf webcite
• [33]Intellectual Property Watch: WHO Members Show Dismay At Delay On Counterfeit Medicines Group. http://www.ip-watch.org/weblog/2011/01/19/who-members-show-dismay-at-delay-on-counterfeit-medicines-group/ webcite
• [34]Mackey TK, Liang BA, Kubic TT: Dangerous doses: fighting fraud in the global medicine supply chain. Foreign Aff 2012.
• [35]World Health Organization: Conclusions and recommendations of the WHO international conference on combating counterfeit medicines: declaration of Rome. http://www.who.int/medicines/services/counterfeit/RomeDeclaration.pdf webcite
• [36]World Health Organization: Sixty-Fifth World Health Assembly: Agenda item 13.13: WHA65.19. http://apps.who.int/medicinedocs/documents/s19994en/s19994en.pdf webcite
• [37]World Health Organization: Report of the First Meeting of the Member State mechanism on substandard/spurious/falsely- labelled/falsified/counterfeit medical products. http://apps.who.int/gb/ssffc/pdf_files/A_MSM1_4-en.pdf webcite
• [38]Mackey TK, Liang BA: A United Nations global health panel for global health governance. Soc Sci Med 2012, 76:12-15.
• [39]United Nations Office on Drugs and Crime: Experts discuss the role of organized crime in the production and trade of fraudulent medicines. http://www.unodc.org/unodc/en/frontpage/2013/February/conference-focuses-on-the-role-of-organized-crime-in-the-trafficking-of-fraudulent-medicines.html?ref=fs4 webcite
• [40]United Nations Office on Drugs and Crime: How UNODC deals with HIV. http://www.unodc.org/unodc/hiv-aids/index.html webcite
• [41]United Nations Office on Drugs and Crime: Think AIDS before you share needles. http://www.unodc.org/unodc/en/frontpage/think-aids-before-you-share-needles.html webcite
• [42]United Nations Office on Drugs and Crime: Criminals rake in $250 billion per year in counterfeit goods that pose health and security risks. http://www.unodc.org/unodc/en/frontpage/2012/July/criminals-rake-in-250-billion-per-year-in-counterfeit-goods-that-pose-health-security-risks-to-unsuspecting-public.html webcite
• [43]Europol: Europol and Interpol enhance cooperation against counterfeiting to transform regional success into global action. https://www.europol.europa.eu/content/press/europol-and-interpol-enhance-cooperation-against-counterfeiting-transform-regional-suc webcite
• [44]Interpol: Global operation strikes at online supply of illegal and counterfeit medicines worldwide. http://www.interpol.int/News-and-media/News-media-releases/2011/PR081 webcite
• [45]Interpol: Interpol and pharmaceutical industry launch global initiative to combat fake medicines. http://www.interpol.int/News-and-media/News-media-releases/2013/PR031 webcite
• [46]World Health Organization: WHO’s role in the prevention and control of medical products of compromised quality, safety and efficacy such as substandard/spurious/falsely-labelled/ falsified/counterfeit medical products. http://apps.who.int/gb/ssffc/pdf_files/A_SSFFC_WG2_3-en.pdf webcite
• [47]World Intellectual Property Organization: WHO, WIPO, WTO Trilateral Cooperation on Public Health, Intellectual Property and Trade. http://www.wipo.int/globalchallenges/en/health/trilateral_cooperation.html webcite
• [48]United Nations: Environmental Governance. http://www.unep.org/pdf/brochures/EnvironmentalGovernance.pdf webcite
• [49]United Nations Environment Programme: United Nations Office for Partnerships. http://www.un.org/partnerships/ webcite
• [50]World Health Organization: Ninth meeting of the WHO Advisory Committee on Safety of Medicinal Products. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/ACSoMP9.pdf webcite
• [51]World Trade Organization: Doha 4th Ministerial - Ministerial declaration. http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_e.htm webcite